Literature DB >> 22696177

Specification of midbrain dopamine neurons from primate pluripotent stem cells.

Jiajie Xi1, Yan Liu, Huisheng Liu, Hong Chen, Marina E Emborg, Su-Chun Zhang.   

Abstract

By sequentially applying sonic hedgehog (C25II) and CHIR99021 (GSK3β inhibitor) to induce the midbrain floor plate (FP) progenitors and fibroblast growth factor 8 (FGF8) to promote dopaminergic differentiation in a chemically defined medium, we have established a robust system for the generation of midbrain dopamine (DA) neurons from human and rhesus monkey embryonic stem cells and induced pluripotent stem cells (PSCs). We found that CHIR99021 specifies diencephalon to hind brain fates in a concentration-dependent manner and only a narrow concentration range of CHIR99021 at a particular window is necessary to induce the midbrain FP progenitors, expressing Corin, En1, FoxA2, and Lmx1a. FGF8 enhances the dopaminergic fate of the progenitors, thus generating DA neurons with midbrain characteristics, including expression of tyrosine hydroxylase, Lmx1a/b, FoxA2, FoxP1, Nurr1, and En1 as well as typical electrophysiological properties. More than half of these DA neurons expressed A9 DA neuron markers Girk2 and ALDH1a1. The new strategy will allow generation of enriched populations of functional midbrain DA neurons from both human and monkey PSCs for disease modeling, drug testing, and potential cell therapy.
Copyright © 2012 AlphaMed Press.

Entities:  

Mesh:

Year:  2012        PMID: 22696177      PMCID: PMC3405174          DOI: 10.1002/stem.1152

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  51 in total

1.  Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency.

Authors:  Bao-Yang Hu; Jason P Weick; Junying Yu; Li-Xiang Ma; Xiao-Qing Zhang; James A Thomson; Su-Chun Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

2.  A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo.

Authors:  Nilima Prakash; Claude Brodski; Thorsten Naserke; Eduardo Puelles; Robindra Gogoi; Anita Hall; Markus Panhuysen; Diego Echevarria; Lori Sussel; Daniela M Vogt Weisenhorn; Salvador Martinez; Ernest Arenas; Antonio Simeone; Wolfgang Wurst
Journal:  Development       Date:  2006-01       Impact factor: 6.868

3.  Identification of intrinsic determinants of midbrain dopamine neurons.

Authors:  Elisabet Andersson; Ulrika Tryggvason; Qiaolin Deng; Stina Friling; Zhanna Alekseenko; Benoit Robert; Thomas Perlmann; Johan Ericson
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

4.  Efficient derivation of functional floor plate tissue from human embryonic stem cells.

Authors:  Christopher A Fasano; Stuart M Chambers; Gabsang Lee; Mark J Tomishima; Lorenz Studer
Journal:  Cell Stem Cell       Date:  2010-04-02       Impact factor: 24.633

5.  Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.

Authors:  Neeta S Roy; Carine Cleren; Shashi K Singh; Lichuan Yang; M Flint Beal; Steven A Goldman
Journal:  Nat Med       Date:  2006-10-22       Impact factor: 53.440

6.  Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin.

Authors:  Kai-Christian Sonntag; Jan Pruszak; Takahito Yoshizaki; Joris van Arensbergen; Rosario Sanchez-Pernaute; Ole Isacson
Journal:  Stem Cells       Date:  2006-10-12       Impact factor: 6.277

7.  Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells.

Authors:  Yiping Yan; Dali Yang; Ewa D Zarnowska; Zhongwei Du; Brian Werbel; Chuck Valliere; Robert A Pearce; James A Thomson; Su-Chun Zhang
Journal:  Stem Cells       Date:  2005 Jun-Jul       Impact factor: 6.277

8.  Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats.

Authors:  Gunnar Hargus; Oliver Cooper; Michela Deleidi; Adam Levy; Kristen Lee; Elizabeth Marlow; Alyssa Yow; Frank Soldner; Dirk Hockemeyer; Penelope J Hallett; Teresia Osborn; Rudolf Jaenisch; Ole Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

9.  Fgf8b-containing spliceforms, but not Fgf8a, are essential for Fgf8 function during development of the midbrain and cerebellum.

Authors:  Qiuxia Guo; Kairong Li; N Abimbola Sunmonu; James Y H Li
Journal:  Dev Biol       Date:  2009-12-05       Impact factor: 3.582

10.  Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype.

Authors:  Cecile Martinat; Jean-Jacques Bacci; Thomas Leete; Jongpil Kim; William B Vanti; Amy H Newman; Joo H Cha; Ulrik Gether; Honggang Wang; Asa Abeliovich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

View more
  89 in total

Review 1.  Understanding Parkinson's Disease through the Use of Cell Reprogramming.

Authors:  Rebecca Playne; Bronwen Connor
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

2.  Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Adult Common Marmoset Fibroblasts.

Authors:  Scott C Vermilyea; Scott Guthrie; Michael Meyer; Kim Smuga-Otto; Katarina Braun; Sara Howden; James A Thomson; Su-Chun Zhang; Marina E Emborg; Thaddeus G Golos
Journal:  Stem Cells Dev       Date:  2017-07-24       Impact factor: 3.272

3.  Real-Time Intraoperative MRI Intracerebral Delivery of Induced Pluripotent Stem Cell-Derived Neurons.

Authors:  Scott C Vermilyea; Jianfeng Lu; Miles Olsen; Scott Guthrie; Yunlong Tao; Eva M Fekete; Marissa K Riedel; Kevin Brunner; Carissa Boettcher; Viktorya Bondarenko; Ethan Brodsky; Walter F Block; Andrew Alexander; Su-Chun Zhang; Marina E Emborg
Journal:  Cell Transplant       Date:  2016-09-14       Impact factor: 4.064

Review 4.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

5.  Selection Based on FOXA2 Expression Is Not Sufficient to Enrich for Dopamine Neurons From Human Pluripotent Stem Cells.

Authors:  Julio Cesar Aguila; Alexandra Blak; Joris van Arensbergen; Amaia Sousa; Nerea Vázquez; Ariane Aduriz; Mayela Gayosso; Maria Paz Lopez Mato; Rakel Lopez de Maturana; Eva Hedlund; Kai-Christian Sonntag; Rosario Sanchez-Pernaute
Journal:  Stem Cells Transl Med       Date:  2014-07-14       Impact factor: 6.940

6.  Impaired mitochondrial dynamics underlie axonal defects in hereditary spastic paraplegias.

Authors:  Kyle Denton; Yongchao Mou; Chong-Chong Xu; Dhruvi Shah; Jaerak Chang; Craig Blackstone; Xue-Jun Li
Journal:  Hum Mol Genet       Date:  2018-07-15       Impact factor: 6.150

Review 7.  Pluripotent stem cells in regenerative medicine: challenges and recent progress.

Authors:  Viviane Tabar; Lorenz Studer
Journal:  Nat Rev Genet       Date:  2014-02       Impact factor: 53.242

8.  Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain.

Authors:  Marina E Emborg; Yan Liu; Jiajie Xi; Xiaoqing Zhang; Yingnan Yin; Jianfeng Lu; Valerie Joers; Christine Swanson; James E Holden; Su-Chun Zhang
Journal:  Cell Rep       Date:  2013-03-14       Impact factor: 9.423

Review 9.  Cell Therapy for Parkinson's Disease: New Hope from Reprogramming Technologies.

Authors:  Zhiguo Chen
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

10.  Generation of serotonin neurons from human pluripotent stem cells.

Authors:  Jianfeng Lu; Xuefei Zhong; Huisheng Liu; Ling Hao; Cindy Tzu-Ling Huang; Mohammad Amin Sherafat; Jeffrey Jones; Melvin Ayala; Lingjun Li; Su-Chun Zhang
Journal:  Nat Biotechnol       Date:  2015-12-14       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.